Genetron Holdings Ltd

CIK:0001782594|SEC Filings

CONSOLIDATED STATEMENTS OF LOSS ¥ in Thousands, $ in Thousands	12 Months Ended
	Dec. 31, 2022 CNY (¥) ¥ / shares	Dec. 31, 2022 USD ($) $ / shares	Dec. 31, 2021 CNY (¥) ¥ / shares	Dec. 31, 2020 CNY (¥) ¥ / shares
Employee benefit expenses
Revenue	¥ 650,706	$ 94,344	¥ 531,950	¥ 424,485
Cost of revenue	(369,278)	(53,540)	(193,983)	(164,268)
Gross profit	281,428	40,804	337,967	260,217
Selling expenses	(364,564)	(52,857)	(343,161)	(246,959)
Administrative expenses	(266,908)	(38,698)	(227,001)	(126,318)
Research and development expenses	(290,286)	(42,087)	(253,950)	(148,999)
Net loss allowance for financial and contract assets	(59,010)	(8,556)	(37,032)	(14,843)
Other income and gains/(losses) - net	(2,666)	(387)	5,329	8,526
Operating expenses	(983,434)	(142,585)	(855,815)	(528,593)
Operating loss	(702,006)	(101,781)	(517,848)	(268,376)
Finance income	2,861	415	20,501	28,330
Finance costs	(111,485)	(16,164)	(5,251)	(5,627)
Finance income/(costs) - net	(108,624)	(15,749)	15,250	22,703
Fair value loss of financial instruments with preferred rights			0	(2,823,370)
Loss before income tax	(810,630)	(117,530)	(502,598)	(3,069,043)
Income tax expense	0		0	0
Loss for the year	(810,630)	(117,530)	(502,598)	(3,069,043)
Loss attributable to:
Owners of the Company	(808,403)	(117,207)	(496,238)	¥ (3,069,043)
Non-controlling interests	¥ (2,227)	$ (323)	¥ (6,360)
Loss per share for loss attributable to owners of the Company
Basic \| ¥ / shares	¥ (1.74)		¥ (1.08)	¥ (10.18)
Ordinary shares [member]
Loss per share for loss attributable to owners of the Company
Basic \| (per share)	(1.74)	$ (0.25)	(1.08)	(10.18)
Diluted \| (per share)	(1.74)	(0.25)	(1.08)	(10.18)
ADS
Loss per share for loss attributable to owners of the Company
Basic \| (per share)	(8.71)	(1.26)	(5.39)	(50.92)
Diluted \| (per share)	¥ (8.71)	$ (1.26)	¥ (5.39)	¥ (50.92)

CONSOLIDATED STATEMENTS OF CASH FLOWS ¥ in Thousands, $ in Thousands	12 Months Ended
	Dec. 31, 2022 CNY (¥)	Dec. 31, 2022 USD ($)	Dec. 31, 2021 CNY (¥)	Dec. 31, 2020 CNY (¥)
Cash flows from operating activities
Cash used in operations	¥ (460,197)	$ (66,722)	¥ (524,144)	¥ (300,897)
Net cash used in operating activities	(460,197)	(66,722)	(524,144)	(300,897)
Cash flows from investing activities
Purchase of property, plant and equipment	(72,078)	(10,450)	(73,489)	(36,655)
Purchase of intangible assets	(10,062)	(1,459)	(12,404)	(13,371)
Purchase of wealth management products	(1,180,045)	(171,090)	(1,650,355)	(1,628,558)
Redemption of wealth management products	1,165,980	169,051	1,623,538	1,620,924
Investment income from wealth management products	3,366	488	4,991	4,476
Purchase of equity security				(13,721)
Purchase of other investments			(28,895)	(19,000)
Purchase of derivative financial instruments	(63,742)	(9,242)	(415,346)	(68,078)
Settlement of derivative financial instruments	65,744	9,532	424,251	69,628
Placement of deposits with initial terms of over three months			(5,000)
Redemption of deposits with initial terms of over three months			5,000
Proceeds from sale of subsidiaries			2,000
Others	3,005	436	(10,566)	(294)
Net cash used in investing activities	(87,832)	(12,734)	(136,275)	(84,649)
Cash flows from financing activities
Proceeds from issuance of ordinary shares				1,676,816
Proceeds from ADS depository				23,069
Proceeds from issuance of financial instruments with preferred rights				70,026
Repurchase of ordinary shares				(4,102)
Proceeds from investors to the Company			48,617	299,051
Repayments to investors from the Group			(48,452)	(314,388)
Proceeds from exercise of awards	843	123	2,169
Capital injection from non-controlling interests			10,821
Proceeds from borrowings	129,973	18,844	25,153	61,213
Repayments of borrowings	(32,979)	(4,782)	(69,106)	(20,703)
Principal elements of lease payments	(21,940)	(3,181)	(21,708)	(19,577)
Interests paid	(6,030)	(874)	(4,899)	(4,942)
Payments in relation to listing expenses			(1,000)	(21,691)
Others	1,500	217		(260)
Net cash generated from/(used in) financing activities	71,367	10,347	(58,405)	1,744,512
Net increase/(decrease) in cash and cash equivalents	(476,662)	(69,109)	(718,824)	1,358,966
Cash and cash equivalents at beginning of year	639,042	92,652	1,375,766
Exchange differences on cash and cash equivalents	13,886	2,013	(17,900)	(123,154)
Cash and cash equivalents at end of year	¥ 176,266	$ 25,556	¥ 639,042	¥ 1,375,766

CONSOLIDATED BALANCE SHEETS ¥ in Thousands, $ in Thousands	Dec. 31, 2022 CNY (¥)	Dec. 31, 2022 USD ($)	Dec. 31, 2021 CNY (¥)
Non-current assets
Property, plant and equipment	¥ 138,753	$ 20,117	¥ 110,285
Right-of-use assets	38,884	5,638	52,074
Intangible assets	32,068	4,649	20,695
Financial assets at fair value through profit or loss	50,496	7,321	49,780
Prepayments	6,173	895	37,610
Total non-current assets	266,374	38,620	270,444
Current assets
Inventories	42,427	6,151	35,603
Contract assets	14,697	2,131	7,775
Other current assets	9,472	1,373	30,705
Trade receivables	243,123	35,250	282,113
Other receivables and prepayments	65,431	9,487	97,895
Amounts due from related parties	110	16	597
Financial assets at fair value through profit or loss	157,426	22,825	151,443
Derivative financial instruments			2,002
Cash and cash equivalents	176,266	25,556	639,042
Total current assets	708,952	102,789	1,247,175
Total assets	975,326	141,409	1,517,619
Non-current liabilities
Borrowings	7,098	1,029
Lease liabilities	20,245	2,935	33,865
Other non-current liabilities	9,760	1,416	8,612
Total non-current liabilities	37,103	5,380	42,477
Current liabilities
Trade payables	63,048	9,141	55,767
Contract liabilities	9,589	1,390	11,962
Other payables and accruals	186,006	26,968	157,232
Amounts due to related parties			3
Borrowings	109,734	15,910	19,554
Lease liabilities	21,490	3,116	20,572
Total current liabilities	389,867	56,525	265,090
Total liabilities	426,970	61,905	307,567
Net assets	548,356	79,504	1,210,052
SHAREHOLDERS' EQUITY
Share capital	61	9	61
Share premium	6,734,905	976,469	6,711,234
Other reserves	56,172	8,144	(69,091)
Accumulated losses	(6,245,016)	(905,442)	(5,436,613)
Total equity attributable to owners of the company	546,122	79,180	1,205,591
Non-controlling interests	2,234	324	4,461
Total shareholders' equity	¥ 548,356	$ 79,504	¥ 1,210,052